NCT06907381

Brief Summary

Recovery of arm and hand motor control is critical for independence and quality of life following incomplete spinal cord injury (iSCI). Blood flow-restricted resistance exercise (BFRE) has emerged as a potential treatment addressing this need, but treatment guidelines and research reporting effectiveness are sparse. The purpose of this work is to provide case reports of people with cervical iSCI who use BFRE supplemented by electrical stimulation (ES) to increase the strength and functional use of selected upper extremity muscles.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
2mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Apr 2025Jun 2026

First Submitted

Initial submission to the registry

March 26, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 2, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

March 26, 2025

Last Update Submit

March 11, 2026

Conditions

Keywords

Blood flow-restricted resistance exercisePhysical therapyRehabilitationElectrical stimulation

Outcome Measures

Primary Outcomes (1)

  • Change in muscle strength

    Change in strength of target muscle(s) contraction as measured in pounds of force using a dynamometer.

    Baseline and end of treatment at a maximum of 6 months

Secondary Outcomes (3)

  • Change in number of repetitions of unassisted target muscle(s) contractions

    Baseline and end of treatment at a maximum of 6 months

  • Change in support required to perform functional task

    Baseline and end of treatment at a maximum of 6 months

  • Change in perceived exertion when performing a functional task

    Baseline and end of treatment at a maximum of 6 months

Interventions

Participants will engage in baseline measurement of blood pressure, strength of target muscle contractions, and level of support needed for functional task performance. They will then begin BFRE treatment supplemented by electrical stimulation, if needed, two times weekly. Each exercise session will include performance of four sets of 20 repetitions of target muscle contraction on each side of the body followed by functional task performance.

Also known as: BFRE

Eligibility Criteria

Age19 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will include adults with incomplete cervical spinal cord injury. They will be medically stable and enrolled in Quality Living's rehabilitation program in Omaha, NE, at the time of participation. Level of injury can vary from C3 to C8. Participants will demonstrate sensory and motor function consistent with AIS B, C, or D classification.

You may qualify if:

  • Incomplete cervical spinal cord injury
  • Resting blood pressure between 80/50 mmHg and 150/90 mmHg for at least three consecutive days
  • Native speaker of English

You may not qualify if:

  • Recent history of deep vein thrombosis or cardiovascular disease including uncontrolled hypertension or a blood-clotting disorder
  • Routine experience of orthostatic hypotension as defined as a drop in systolic/diastolic blood pressure greater than 20/10 mmHg when engaging in physical activity
  • Severe cognitive, communication, or behavioral disorder as determined by treatment team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Quality Living, Inc.

Omaha, Nebraska, 68104, United States

Location

Study Officials

  • Sara Waid, DPT

    Quality Living, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2025

First Posted

April 2, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 15, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations